Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Pak Fah Yeow International Limited ( (HK:0239) ).
Pak Fah Yeow International Limited has declared a final ordinary dividend of HKD 0.038 per share for the financial year ended 31 December 2025, underscoring its continued commitment to returning cash to shareholders. The dividend, subject to shareholder approval on 2 June 2026, will be paid on 7 August 2026, with the ex-dividend date set for 6 July and the record date on 10 July, providing investors with clear timelines for entitlement.
The announcement signals stable financial management and reinforces the company’s role as a consistent dividend payer within Hong Kong’s consumer and healthcare-related sector. The detailed schedule around book closure and payment also offers transparency for existing and prospective investors, while the unchanged withholding tax position suggests no additional tax complications for recipients of the payout.
The most recent analyst rating on (HK:0239) stock is a Buy with a HK$2.50 price target. To see the full list of analyst forecasts on Pak Fah Yeow International Limited stock, see the HK:0239 Stock Forecast page.
More about Pak Fah Yeow International Limited
Pak Fah Yeow International Limited is a Hong Kong-listed company best known for its medicated oils and related healthcare products, with a primary focus on the Greater China and Asian consumer markets. The group operates as a traditional branded healthcare player, using steady cash generation from its core products to support shareholder returns and maintain its market presence.
Average Trading Volume: 50,087
Technical Sentiment Signal: Buy
Current Market Cap: HK$741.7M
For a thorough assessment of 0239 stock, go to TipRanks’ Stock Analysis page.

